戻る
「早戻しボタン」を押すと検索画面に戻ります。

今後説明を表示しない

[OK]

コーパス検索結果 (1語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1 hydrometrocolpos, post-axial polydactyly and congenital heart defects).
2 ydrometrocolpos, post-axial polydactyly, and congenital heart defects).
3 genic CHD7 mutation, of whom 220 (74%) had a congenital heart defect.
4  of Fallot (TOF) is the most common cyanotic congenital heart defect.
5  report characterizing ncRNA expression in a congenital heart defect.
6  factors contribute to the presentation of a congenital heart defect.
7 the ductus arteriosus, the third most common congenital heart defect.
8 ntricular septal defects are the most common congenital heart defect.
9 hanical signaling and MET in the etiology of congenital heart defects.
10 ic abnormalities; myopia was correlated with congenital heart defects.
11 ial to mitigate poor growth in children with congenital heart defects.
12  feeding and growth pattern in children with congenital heart defects.
13 elopmental disorder characterized in part by congenital heart defects.
14                          This is relevant to congenital heart defects.
15 also associated with cardiac hypertrophy and congenital heart defects.
16 centers of the German Competence Network for Congenital Heart Defects.
17 cases and 49.06% (35.06-63.16) for all major congenital heart defects.
18  28.57% (14.64-46.30) for all cases of major congenital heart defects.
19 s in FGF3 or FGF10 could contribute to human congenital heart defects.
20 cy of pulse oximetry as a screening test for congenital heart defects.
21 ons with a variety of syndromic and isolated congenital heart defects.
22 sity is associated with an increased risk of congenital heart defects.
23 tus arteriosus and is one of the most common congenital heart defects.
24 s necessary to improve repair strategies for congenital heart defects.
25 deling contribute to the etiology of several congenital heart defects.
26 intricate steps of cardiogenesis can lead to congenital heart defects.
27 erhaps defects in this signal play a role in congenital heart defects.
28 e formation of the OFT can result in serious congenital heart defects.
29 pacing technologies to younger patients with congenital heart defects.
30 otect against other birth defects, including congenital heart defects.
31 en found to be responsible for some cases of congenital heart defects.
32 greater understanding of the pathogenesis of congenital heart defects.
33 athic PAH and 2 with PAH in association with congenital heart defects.
34 ght ultimately result in particular types of congenital heart defects.
35  panic disorder), epilepsy, asthma, and some congenital heart defects.
36 d received allograft placement for repair of congenital heart defects.
37 irment could be a significant contributor to congenital heart defects.
38 overing mutations causing a wide spectrum of congenital heart defects.
39 thogenesis of both structural and functional congenital heart defects.
40 wledge about the molecular genetic causes of congenital heart defects.
41 apid identification of disease genes causing congenital heart defects.
42 ecurrence risk for families of children with congenital heart defects.
43 pressed in patients with Down's syndrome and congenital heart defects.
44 atients who underwent open-heart surgery for congenital heart defects.
45  have been proposed as a mechanism for human congenital heart defects.
46 or hemodynamic abnormalities associated with congenital heart defects.
47 rafts to alleviate stenosis during repair of congenital heart defects.
48 of nonvalved allograft tissue used to repair congenital heart defects.
49  retardation, craniofacial abnormalities and congenital heart defects.
50  into the genetic contribution to structural congenital heart defects.
51 eas for future research on and prevention of congenital heart defects.
52 ylaxis for children and adults with repaired congenital heart defects.
53 g cardiopulmonary bypass (CPB) for repair of congenital heart defects.
54 y hypertension in the presence or absence of congenital heart defects.
55 y loci involved in complex disorders such as congenital heart defects.
56 on in this process has major implications in congenital heart defects.
57 raction in postnatal cardiac development and congenital heart defects.
58 type of LQTS, HCM, sudden cardiac death, and congenital heart defects.
59  oxygen species (ROS) levels and the risk of congenital heart defects.
60 short stature, craniofacial dysmorphism, and congenital heart defects.
61 2-8 of pregnancy and their associations with congenital heart defects.
62  highly penetrant and associated with varied congenital heart defects.
63  of women whose pregnancies were affected by congenital heart defects (224 case subjects) or unaffect
64  of women whose pregnancies were affected by congenital heart defects (331 cases) and in a control gr
65 .1 years) because of cardiomyopathy (66%) or congenital heart defects (34%).
66 ardiac abnormalities were diagnosed, such as congenital heart defects (6%), mitral valve abnormalitie
67                                              Congenital heart defects affect at least 0.8% of newborn
68                                              Congenital heart defects also are common in patients wit
69 ach high standards of care for children with congenital heart defects, although more data would be ne
70 re not able to demonstrate a higher risk for congenital heart defect among monozygotic twins compared
71   Bicuspid aortic valve (BAV) is a heritable congenital heart defect and an important risk factor for
72  aortic valve (BAV) is the most common adult congenital heart defect and is found in 0.5% to 2.0% of
73                   Ten patients with cyanotic congenital heart defects and 10 control subjects were st
74 rovide new insights into the pathogenesis of congenital heart defects and 22q11.2 deletion syndrome p
75      Case infants (n = 998) had nonsyndromic congenital heart defects and control infants (n = 3,029)
76 nts of Chromosome 8p23.1 are associated with congenital heart defects and developmental delay.
77 with variable penetrance identified in other congenital heart defects and dilated cardiomyopathy, thi
78 yos, which will enhance our understanding of congenital heart defects and heart disease.
79 der characterized by post-axial polydactyly, congenital heart defects and hydrometrocolpos, a congeni
80 rge pedigree with concomitant LQTS, HCM, and congenital heart defects and identified a novel CACNA1C
81 tion accounts for approximately 30% of human congenital heart defects and manifests frequently in TBX
82 ios (ORs) for associations between offspring congenital heart defects and maternal hypertensive disor
83     Both technologies produce novel views of congenital heart defects and offer improved quantificati
84 conceptional folic acid on the occurrence of congenital heart defects and orofacial clefts is reporte
85 ic acid and a reduction in the occurrence of congenital heart defects and orofacial clefts.
86 iological mechanisms may be involved in some congenital heart defects and preterm preeclampsia.
87                                Patients with congenital heart defects and stenotic or occluded IFV/IV
88 he genetic/epigenetic pathways implicated in congenital heart defects and the mechanisms of cardiac t
89  approaches to understanding the etiology of congenital heart defects and the repair of diseased card
90 will be important to understand the basis of congenital heart defects and to derive cardiac regenerat
91 rol study was conducted in infants born with congenital heart defects and unaffected controls from th
92 nts with Holt-Oram syndrome characterized by congenital heart defects and upper limb abnormalities.
93 ns cause Holt-Oram syndrome characterized by congenital heart defects and upper limb deformations.
94 ht ventricular dysplasia; and delineation of congenital heart defects and valvular abnormalities are
95  This mutation causes heterotaxy and complex congenital heart defects and was mapped to a 2.2-Mb inte
96 h six cases were significant, but not major, congenital heart defects, and 40 were other illnesses th
97 of clinical features including growth delay, congenital heart defects, and craniofacial dysmorphism.
98 ith absent speech, hypotonia, brachycephaly, congenital heart defects, and dysmorphic facial features
99 ve malformations with associated aortopathy, congenital heart defects, and genetic syndromes.
100 ral CNS anomalies, ophthalmologic anomalies, congenital heart defects, and genitourinary abnormalitie
101                Thirty-six patients (40%) had congenital heart defects, and many (31 [86%]) had associ
102 sed risk of bearing children with a range of congenital heart defects, and the risk increases with in
103 k of sudden death after operation for common congenital heart defects; and 2) factors associated with
104 a complex phenotype including LQTS, HCM, and congenital heart defects annotated as cardiac-only Timot
105                                              Congenital heart defects are a major cause of perinatal
106  cohort study to determine whether offspring congenital heart defects are associated with an increase
107    Implications for the development of human congenital heart defects are discussed.
108                                              Congenital heart defects are generally assumed to have a
109                          Children with major congenital heart defects are risking impaired cerebral g
110                                              Congenital heart defects are the most common birth defec
111                                              Congenital heart defects are the most frequent malformat
112 alve morphogenesis involved in the origin of congenital heart defects associated with reduced NOTCH f
113 nd ventricular septum defect, which resemble congenital heart defects attributed to defects in the NC
114  transcription factors cannot only result in congenital heart defects but also alter heart function t
115 ors likely contribute to the pathogenesis of congenital heart defects, but it is unclear whether indi
116 trongest evidence that multivitamins prevent congenital heart defects, but this RCT did not provide e
117 ong women whose pregnancies were affected by congenital heart defects cannot be defined without furth
118                              Mothers of 7392 congenital heart defect cases and 56,304 unaffected cont
119  of pulse oximetry for detection of critical congenital heart defects (causing death or requiring inv
120 eening method to detect undiagnosed critical congenital heart defects (CCHD) in asymptomatic newborns
121     Hypoplastic left heart is a severe human congenital heart defect characterized by left ventricula
122 ibrillator (ICD) placement in paediatric and congenital heart defect (CHD) patients.
123 c patent ductus arteriosus (PDA) is a common congenital heart defect (CHD) with both inherited and ac
124 ately 65% of individuals with 22q11DS have a congenital heart defect (CHD), mostly of the conotruncal
125  About half of people with trisomy 21 have a congenital heart defect (CHD), whereas the remainder hav
126                                              Congenital heart defect (CHD)-related death rates correl
127 n our understanding of the genetic causes of congenital heart defect (CHD).
128 cts (heterotaxy) that were associated with a congenital heart defect (CHD).
129                                              Congenital heart defects (CHD) are collectively the most
130                                              Congenital heart defects (CHD) are the leading cause of
131                       More children die from congenital heart defects (CHD) each year than are diagno
132  pulmonary hypertension (PHT) and associated congenital heart defects (CHD) has not been evaluated.
133 ing neurocognitive outcomes in children with congenital heart defects (CHD) have focused on high-risk
134 ion in a patient with pathogenically similar congenital heart defects (CHD) to narrow the putative cr
135      This study determines the prevalence of Congenital Heart Defects (CHD), diagnosed prenatally or
136 ic modalities and therapeutic strategies for congenital heart defects (CHD), these malformations stil
137 some 21 (Hsa21), is the most common cause of congenital heart defects (CHD), yet the genetic and mech
138  who undergo early cardiac surgery to repair congenital heart defects (CHD).
139 cription factor NKX2.5 as a cause of various congenital heart defects (CHD).
140 nd distressful comorbidities associated with congenital heart defects (CHD).
141 on (AF) is rising in the aging patients with congenital heart defects (CHD).
142 sociated with an increased risk of offspring congenital heart defects (CHD); however, the causal mech
143                                              Congenital heart defects (CHDs) affect 2%-3% of newborns
144 en maternal medical conditions/illnesses and congenital heart defects (CHDs) among infants.
145                                              Congenital heart defects (CHDs) and anomalies in cardiac
146                                              Congenital heart defects (CHDs) are among the most commo
147                                        While congenital heart defects (CHDs) are major clinical featu
148                                              Congenital heart defects (CHDs) are the most common birt
149                                              Congenital heart defects (CHDs) are the most common deve
150                                              Congenital heart defects (CHDs) are the most common grou
151                                              Congenital heart defects (CHDs) are the result of abnorm
152         Maternal diabetes is associated with congenital heart defects (CHDs) as a group, but few stud
153                                              Congenital heart defects (CHDs) have a neonatal incidenc
154                                              Congenital heart defects (CHDs) have a neonatal incidenc
155                                              Congenital heart defects (CHDs) have been associated wit
156 rythematosus (SLE) have an increased risk of congenital heart defects (CHDs) in comparison with child
157 patterns with neural tube defects (NTDs) and congenital heart defects (CHDs) in the U.S. National Bir
158 O2, NO2, CO are related to increased risk of congenital heart defects (CHDs) in Wuhan, China.
159 first-trimester screening on the spectrum of congenital heart defects (CHDs) later in pregnancy and o
160 of the results achieved by modern surgery in congenital heart defects (CHDs) over the past 40 years r
161 , there has been a decline in mortality from congenital heart defects (CHDs) over the past several de
162 congenital malformations in humans including congenital heart defects (CHDs), left-right disturbances
163 ease almost always are attributed to complex congenital heart defects (CHDs), reflecting the extreme
164 ed in patients with isolated or nonsyndromic congenital heart defects (CHDs).
165 ecting patients have phenotypes that include congenital heart defects (CHDs).
166 acid and of folic acid food fortification on congenital heart defects (CHDs).
167 ide a rationale for attempting prevention of congenital heart defects (CHDs).
168 scription factor genes cause human inherited congenital heart defects (CHDs); however, their molecula
169 n B6)), was associated with a lower risk for congenital heart defects compared with: 1) absence of na
170                                              Congenital heart defects comprise the most common form o
171 ice were subviable, smaller in size, and had congenital heart defects, consistent with the severity o
172                         By contrast, complex congenital heart defects continue to require open-heart
173 cal and sub-clinical vascular brain lesions, congenital heart defects, coronary heart disease, psychi
174      Presence of any critical or noncritical congenital heart defect detected in infants at birth, co
175 e recently been reported in association with congenital heart defects, developmental delay, schizophr
176  collected data on all operations (1378) for congenital heart defects done by 11 surgeons in five dep
177 fidence interval, 45-82%] increased risk for congenital heart defect for twins).
178  of hCPCs in young patients with nonischemic congenital heart defects for potential use in congenital
179  In this review, progress in identifying new congenital heart defect genes for specific lesions and i
180                          The occurrence of a congenital heart defect has long been thought to have a
181                        In the recent era, no congenital heart defect has undergone a more dramatic ch
182  Improvement in outcome of infants born with congenital heart defects has been accompanied by an incr
183 though the care of infants and children with congenital heart defects has been revolutionized over th
184 CSCs in very young patients with nonischemic congenital heart defects has not been explored.
185 Bicuspid aortic valve (BAV), the most common congenital heart defect, has been thought to cause frequ
186 egnancies that were affected by nonsyndromic congenital heart defects have alterations in the homocys
187     In severe SMA cases, a growing number of congenital heart defects have been identified upon autop
188 esting may become standard for many forms of congenital heart defects, improving clinicians' ability
189 e NP, was associated with a lower risk for a congenital heart defect in the child (odds ratio (OR) =
190    Hypoplastic left heart syndrome is a rare congenital heart defect in which the left side of the he
191 though underlying heart disease was present (congenital heart defects in 10 and dilated cardiomyopath
192                  We collected information on congenital heart defects in 299 patients with a pathogen
193                                    Offspring congenital heart defects in a previous pregnancy were al
194  dysmorphia, increased risk of leukemia, and congenital heart defects in approximately 50% of cases.
195 reening method for the detection of critical congenital heart defects in asymptomatic newborn babies.
196 pulse oximetry for the detection of critical congenital heart defects in asymptomatic newborn babies.
197 A public inquiry into surgery for paediatric congenital heart defects in Bristol, UK, underscored the
198             Allografts used in the repair of congenital heart defects in children induce a persistent
199                                 Treatment of congenital heart defects in children requiring right ven
200  may be a viable strategy for suppression of congenital heart defects in fetuses of diabetic pregnanc
201 pina bifida, cleft lip, anal atresia, severe congenital heart defects in general, or tetralogy of Fal
202 ations in a Hox mouse model, which mimic the congenital heart defects in HOXA1 syndrome patients.
203 he MEF2C and TDGF1 genes are associated with congenital heart defects in humans.
204 ations in GATA4 and TBX5 are associated with congenital heart defects in humans.
205                                  The risk of congenital heart defects in infants of women who had pre
206  that perturb neural crest development cause congenital heart defects in laboratory animals and in ma
207  hypertension, was associated with offspring congenital heart defects in later pregnancies (early pre
208 ington Infant Study, a case-control study of congenital heart defects in liveborn infants conducted i
209               Identification of ASD or other congenital heart defects in more than one family member
210 tool for the preoperative diagnosis of major congenital heart defects in most children undergoing pri
211 d mortality after the surgical correction of congenital heart defects in neonatal patients.
212                       Screening for critical congenital heart defects in newborn babies can aid in ea
213 f NFAT, suggesting a potential mechanism for congenital heart defects in Noonan syndrome.
214  intake of methyl nutrients, and the odds of congenital heart defects in offspring.
215 as been associated with an increased risk of congenital heart defects in offspring; however, the resu
216 on genetic cause of cognitive impairment and congenital heart defects in the human population.
217 on, 316 children with sporadic, nonsyndromic congenital heart defects, including 76 coarctation of th
218  TBX20 are associated with multiple forms of congenital heart defects, including cardiac septal abnor
219     Sema3D morphants have subsequent complex congenital heart defects, including hypertrophic cardiom
220 se mutations are highly penetrant for varied congenital heart defects, including progressive atrioven
221  the cardiac outflow tract (OFT) causes many congenital heart defects, including those associated wit
222 le the survival of infants and children with congenital heart defects, including those with univentri
223                                              Congenital heart defects, inguinal hernia, or hypospadia
224 omalous pulmonary venous return (TAPVR) is a congenital heart defect inherited via complex genetic an
225                                         Many congenital heart defects involve anomalies in cardiac se
226                                              Congenital heart defects involving left-sided lesions (L
227                                              Congenital heart defect is more common in twins than in
228  for patients surviving operation for common congenital heart defects is 25 to 100 times greater than
229     Although the prognosis for patients with congenital heart defects is improved by surgical treatme
230                    Elucidating the causes of congenital heart defects is made difficult by the comple
231 ective endocarditis after surgical repair of congenital heart defects is unknown.
232                                  The type of congenital heart defect, maternal body mass index (BMI;
233 s and many case series reports indicate that congenital heart defects may be more common in monochori
234 d in all 24 probands and three parents, with congenital heart defects most frequent (83%).
235 eview of 1- and 2-year outcomes of a Complex Congenital Heart Defect Neurodevelopmental Follow-Up pro
236 ions such as those with sickle cell disease, congenital heart defects, neutropenia, and indwelling ce
237 some 16, trisomy of which is associated with congenital heart defects observed in Down syndrome.
238                                              Congenital heart defects occur at a rate of 5% and are t
239 ined that a wide spectrum of the most common congenital heart defects occur in 11q-, including an unp
240                                         More congenital heart defects occurred in the offspring of af
241                              We investigated congenital heart defect occurrence in all twins and 5% o
242 twins compared with dizygotic twins, and the congenital heart defect occurrence was also increased in
243 women (BMI: 19-24.9) to have children with a congenital heart defect [odds ratio (OR): 1.15; 95% CI:
244 sing the SNF1LK locus has been implicated in congenital heart defects often observed in patients with
245                                              Congenital heart defects often result from improper diff
246 he chance that offspring will be born with a congenital heart defect or an orofacial cleft are review
247 ntified pregnancies complicated by offspring congenital heart defects or early preterm preeclampsia,
248  incidence of endocarditis after surgery for congenital heart defect, particularly valvular aortic st
249 as a molecular signature that differentiated congenital heart defect phenotypes.
250      Because atrial incisions from repair of congenital heart defects provide a substrate for re-entr
251                  This new model for a common congenital heart defect provides novel insights into the
252 tions in live born null mice include complex congenital heart defects, pulmonary reversal or isomeris
253                     Some Hug mutants exhibit congenital heart defects ranging from mild pulmonary ste
254 dividuals, a total of 584 twins (1.4%) had a congenital heart defect registered in the Danish Nationa
255                                Screening for congenital heart defects relies on antenatal ultrasonogr
256                                              Congenital heart defects remain a leading cause of infan
257 ntrolling AHF development and their roles in congenital heart defects remain incompletely elucidated.
258 ongenital heart defects for potential use in congenital heart defect repair warrants exploration.
259                                     Isolated congenital heart defects resulting from isomerisms and d
260 s, a metabolic profile that is predictive of congenital heart defect risk would help to refine curren
261  neural crest in chick embryos and resembles congenital heart defects seen in humans.
262 dividuals typically have mental retardation, congenital heart defects, seizures, a characteristic fac
263  of Down's syndrome were more likely to list congenital heart defects (SMOR 29.1, 95% CI 27.8-30.4),
264 re is a lack of comparable data for specific congenital heart defects such as in repaired tetralogy o
265 included 49 articles that focused on complex congenital heart defects such as tetralogy of Fallot, sy
266 inheritance of NKX2.5 mutations with various congenital heart defects suggests that this transcriptio
267 September 30, 1997, who were recovering from congenital heart defect surgery and had transthoracic in
268 higher in women with pregnancies affected by congenital heart defects than in women without such a hi
269 -5-expressing cells leads to the most common congenital heart defect that is also a subset of abnorma
270 NKX2.5 mutations were found in patients with congenital heart defects that are transmitted in an auto
271 to characterize three patients with 11q- and congenital heart defects that carry interstitial deletio
272              It identifies cases of critical congenital heart defects that go undetected with antenat
273 k suggests a role for the SHF in a subset of congenital heart defects that have overriding aorta and
274 gene(s) that causes at least a subset of the congenital heart defects that occur in 11q-.
275 rnal metabolic risk profile for nonsyndromic congenital heart defects that would enhance current prev
276  whenever IART occurs late after repair of a congenital heart defect, the atrial flutter isthmus shou
277                                              Congenital heart defects, the majority of which affect t
278          It is not clear whether the risk of congenital heart defects, the most common malformations,
279 gation deficiencies lead to life-threatening congenital heart defects, the variables controlling the
280    Although genetic variation contributes to congenital heart defects, their precise molecular bases
281 e being made to prevent fetal hydrops due to congenital heart defects, to recruit hypoplastic ventric
282 D13L), which is mutated in patients with the congenital heart defect transposition of the great arter
283 reoperative diagnosis of children with major congenital heart defects undergoing primary complete rep
284  during pregnancy and her child's risk for a congenital heart defect using data from the population-b
285  of pulse oximetry for detection of critical congenital heart defects was 76.5% (95% CI 67.7-83.5).
286                   The absolute prevalence of congenital heart defects was higher for infants of women
287                However, the absolute risk of congenital heart defects was low.
288 alse-positive rate for detection of critical congenital heart defects was particularly low when newbo
289 dditional affected individual with RHD and a congenital heart defect, we found a homozygous loss-of-f
290                                 In 35 cases, congenital heart defects were already suspected after an
291 ifferent ages undergoing cardiac surgery for congenital heart defects were isolated and cultured unde
292 ifferent ages undergoing cardiac surgery for congenital heart defects were isolated and cultured unde
293                                              Congenital heart defects were noted in four of the five
294                                    Offspring congenital heart defects were strongly associated with e
295 ight also provide clues to better understand congenital heart defects, which are the most common birt
296 in half of newborn mice mainly associated to congenital heart defects, while Loxl2 overexpression tri
297 iewed the records of 503 children with major congenital heart defects who underwent primary complete
298 ighly significant trend of increasing OR for congenital heart defects with increasing maternal obesit
299 is highly specific for detection of critical congenital heart defects with moderate sensitivity, that
300        We identified 113 candidate genes for congenital heart defects within these CNVs, including BT

WebLSDに未収録の専門用語(用法)は "新規対訳" から投稿できます。
 
Page Top